1. The Antifungal Pipeline: Fosmanogepix, Ibrexafungerp, Olorofim, Opelconazole, and Rezafungin

   • Martin Hoenigl
   • Rosanne Sprute
   • Jeffrey D. Jenks

   Leading Article Open access 09 October 2021 Pages: 1703 - 1729

   

2. Targeting the Angiopoietin/Tie Pathway: Prospects for Treatment of Retinal and Respiratory Disorders

   • Racheal Grace Akwii
   • Constantinos M. Mikelis

   Review Article 29 September 2021 Pages: 1731 - 1749

   

3. Bimekizumab for the Treatment of Psoriasis

   • Egídio Freitas
   • Andrew Blauvelt
   • Tiago Torres

   Review Article 08 October 2021 Pages: 1751 - 1762

   

4. REal worlD Effectiveness and Safety of Mepolizumab in a Multicentric Spanish Cohort of Asthma Patients Stratified by Eosinophils: The REDES Study

   • Christian Domingo Ribas
   • Teresa Carrillo Díaz
   • the REDES Study Group

   Original Research Article Open access 29 September 2021 Pages: 1763 - 1774

   

5. Furmonertinib: First Approval

   • Emma D. Deeks

   AdisInsight Report 15 September 2021 Pages: 1775 - 1780

   

6. Odevixibat: First Approval

   • Emma D. Deeks

   AdisInsight Report Open access 09 September 2021 Pages: 1781 - 1786

   

7. Finerenone: First Approval

   • James E. Frampton

   AdisInsight Report 14 September 2021 Pages: 1787 - 1794

   

8. Anifrolumab: First Approval

   • Emma D. Deeks

   AdisInsight Report 23 September 2021 Pages: 1795 - 1802

   

9. Avalglucosidase alfa: First Approval

   • Sohita Dhillon

   AdisInsight Report 30 September 2021 Pages: 1803 - 1809

   

10. Correction to: Tralokinumab: First Approval

    • Sean Duggan

    Correction Open access 17 September 2021 Pages: 1811 - 1811

11. Correction to: Tralokinumab: First Approval

    • Sean Duggan

    Correction Open access 24 September 2021 Pages: 1813 - 1813

12. Correction to: Odevixibat: First Approval

    • Emma D. Deeks

    Correction Open access 23 September 2021 Pages: 1815 - 1815

13. Correction to: Netupitant/Palonosetron: A Review in Chemotherapy-Induced Nausea and Vomiting

    • Matt Shirley

    Correction Open access 24 September 2021 Pages: 1817 - 1817

14. Correction to: Hyperkalemia in Chronic Kidney Disease in the New Era of Kidney Protection Therapies

    • José M. Valdivielso
    • Olga Balafa
    • Alberto Ortiz

    Correction 11 October 2021 Pages: 1819 - 1819